News
12-04-2007, 03:45 AM
Amgen Inc said on Friday interim results from an independent studyinvolving breast cancer patients found its anemia drug Aranesp didnot enhance the effect of chemotherapy prior to surgery.
More... (http://www.healthcentral.com/breast-cancer/news-196697-66.html)
More... (http://www.healthcentral.com/breast-cancer/news-196697-66.html)